Friday, July 6, 2012

Biotech Investor Trading Alert: Sunshine Biopharma (OTCBB: SBFM)

Biotech Investor Trading Alert: Sunshine Biopharma (OTCBB: SBFM)7/6/12 Palm Beach, FL (StreetBeat) --, an investor research portal specializing in sector research including biotech and pharma stocks, issued yesterday a trading alert for Sunshine Biopharma Inc. (OTCBB: SBFM). The stock closed at $0.49, up $ 0.17 or (36%) on 247,000 shares.

Sunshine Biopharma is a pharmaceutical company focused on the research, development and commercialization of drugs for the treatment of various forms of cancer. The Company’s lead compound, Adva-27a targets aggressive forms of cancer.

Last week the Company reported that it had completed a cytotoxicity study of its lead compound, Adva-27a, in H69AR, a Multidrug Resistant Small Cell Lung Cancer cell line. Cytotoxicity studies measure the ability of a drug to destroy cancer cells in vitro. The results of the study showed that Adva-27a is significantly more effective at killing Multidrug Resistant Small Cell Lung Cancer cells than Etoposide, the current commonly used drug for this type of cancer. This is the second form of Multidrug Resistant Cancer that Adva-27a has shown effectiveness against. The first, which we had announced on July 11, 2011, was MCF-7/MDR Multidrug Resistant Breast Cancer.

About Sunshine Biopharma Inc. (OTCBB: SBFM)

About is a leader in investor stock research by sector, including biotech and pharma stocks. Visit the biotech portal within Investor Ideas:

Follow on Twitter!/Investorideas
Follow on Facebook

Sign up for the free investor news and biotech stock alerts

Research biotech stocks at the Investor Ideas Biotech stocks Directory

Disclaimer/ Disclosure : The is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. Disclosure: A third party on behalf of SBFM compensated for news release publishing and distribution: one hundred thousand 144 shares for three months starting June 26th
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info:

800-665-0411 - Source –

StreetBeat Disclaimer

Distributed by Viestly

No comments:

Post a Comment